Target intelligence / Profile preview

Beta-fructofuranosidase

Molecular classification
Enzyme, Hydrolase, Glycoside hydrolase family 32 (GH32)
01

Overview

Beta-fructofuranosidase (EC 3.2.1.26), also commonly called invertase, is an enzyme that catalyzes the hydrolysis of sucrose into glucose and fructose by cleaving the terminal non-reducing β-D-fructofuranoside residues in β-D-fructofuranosides[2][3][10]. It is widely used in the food industry for the production of invert sugar syrups, in baking, for sucrose-based fermented beverages, and other processes[2][3]. The most common industrial source is the yeast Saccharomyces cerevisiae, though it can also be produced by various fungi and bacteria[6][9]. The enzyme is generally recognized as safe, with a very low risk of allergenicity though cross-reactivity in tomato-allergic individuals has been documented[3][5]. It is not a direct therapeutic target in medicine but is crucial industrially for carbohydrate modification and processing.

Other names
Invertaseβ-D-fructofuranoside fructohydrolaseSaccharaseGlucosucraseBeta-fructosidase
02

Mechanism of action

Catalyzes the hydrolysis of terminal non-reducing β-D-fructofuranoside residues in β-D-fructofuranosides, mainly sucrose, releasing fructose and glucose[1][2][10].

03

Biological functions

Hydrolysis of sucrose into glucose and fructoseCarbohydrate metabolismProduction of invert sugar syrups
04

Disease associations

Other (no direct linkage as a disease target; generally not implicated in human disease but can be relevant in food allergy in rare contexts)
05

Safety considerations

Potential allergenicity, especially in individuals with tomato allergy, but overall risk is considered low[3][5].There are no significant toxicological concerns in food or industrial applications[3][4][5].
06

Interacting drugs

None (no known therapeutics directly targeting this enzyme for disease-modifying effect; it is mostly a food/industrial enzyme)
07

Biomarkers

None (not used as a clinical biomarker for disease or patient selection)

Beyond the preview

Go deeper on Beta-fructofuranosidase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-fructofuranosidase.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call